Startell Bioceuticals

Manufacturing and distributing innovative pharmaceutical medicines in India and the USA.

About Startell Bioceuticals

Startell Bioceuticals is a Healthcare company. Manufacturing and distributing innovative pharmaceutical medicines in India and the USA. The company has 58 employees. Its Indian entity Startell Bioceuticals Private Limited reported revenue of β‚Ή7.08 Cr. Startell Bioceuticals offers products and services including Medicines and Health Solutions. Its focus areas include Biotechnology, Bioceuticals Development, Innovative Medicines and Pharmaceuticals.

Company details

Startell Bioceuticals is recognized as an emerging entity in the Indian pharmaceutical industry, where high-quality medicines are provided across various therapeutic categories to enhance human health. A commitment to ethics and integrity is maintained, with innovative and cost-effective solutions being offered to improve lives. Operations are based in India and the USA, emphasizing collaboration to achieve excellence in medicine delivery. Trust and efficiency are prioritized in all activities, ensuring accessibility for all.

  • Employees 58
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website startellbio.com
  • Legal Name Startell Bioceuticals Pvt. Ltd
  • Date of Incorporation 25 Apr, 2016
  • Jurisdiction Majiwada, Maharashtra, India
Key Metrics
  • Indian entity revenue
    ₹7.08 Cr

    FY 2025 · +30% YoY

  • Indian entity net profit
    ₹8.1 Lakh

    FY 2025 · 1% margin

  • Indian entity EBITDA
    ₹17.1 Lakh

    FY 2025 · 2% margin

  • Employee Count
    58

Products & Services of Startell Bioceuticals

Startell Bioceuticals offers a comprehensive portfolio of products and services, including Medicines and Health Solutions.

Medicines
Pharmaceutical Products

Innovative and cost-effective medicines are provided across various therapeutic categories to enhance human health

Health Solutions
Healthcare Services

Solutions are offered to improve human life through high-quality and ethical pharmaceutical practices

Board of directors of Startell Bioceuticals Private Limited (Startell Bioceuticals)

Startell Bioceuticals Private Limited is the primary company behind Startell Bioceuticals. The board of Startell Bioceuticals Private Limited currently have 2 directors; the longest-serving is Bijal Kalpesh Desai, appointed in 2016. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Bijal Kalpesh Desai
DIN 07477776
Director25 Apr 201610 yrs 6 moStartell Bioceuticals Private Limited
Nilesh Ramesh Sarode
DIN 05115568
Director05 May 20251 yr 6 moStartell Bioceuticals Private Limited

Financials of Startell Bioceuticals

Figures of Startell Bioceuticals Private Limited, the primary company behind Startell Bioceuticals, for FY 2025. Revenue was ₹7.08 Cr (+30% year on year). Net profit was ₹8.1 Lakh (1% margin). EBITDA was ₹17.1 Lakh (2% margin). Revenue has grown at a compounded annual rate of +18% over three years and -1% over five years.

  • ₹7.08 CrRevenue · FY 2025 · +30% YoY
  • ₹8.1 LakhNet profit · 1% margin
  • ₹17.1 LakhEBITDA · 2% margin
  • ₹35 LakhPaid-up capital
  • 58Employees (provident fund records)
  • +18%Revenue CAGR, 3 years
  • -1%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Startell Bioceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Startell Bioceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Startell Bioceuticals

Startell Bioceuticals has 58 employees.

The primary company behind Startell Bioceuticals, Startell Bioceuticals Private Limited, reported revenue of β‚Ή7.08 Cr for FY 2025, up 30% year on year.

Startell Bioceuticals is recognized as an emerging entity in the Indian pharmaceutical industry, where high-quality medicines are provided across various therapeutic categories to enhance human health. A commitment to ethics and integrity is maintained, with innovative and cost-effective solutions being offered to improve lives. Operations are based in India and the USA, emphasizing collaboration to achieve excellence in medicine delivery. Trust and efficiency are prioritized in all activities, ensuring accessibility for all.

Startell Bioceuticals offers Medicines and Health Solutions.

Startell Bioceuticals operates through Startell Bioceuticals Private Limited.

The legal entities of Startell Bioceuticals currently have 2 directors, including Nilesh Ramesh Sarode, Bijal Kalpesh Desai.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available